FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2065403921> ?p ?o ?g. }

• W2065403921 endingPage "458" @default.
• W2065403921 startingPage "448" @default.
• W2065403921 abstract "The non-essential amino acid, glycine, is often considered biologically neutral, but some studies indicate that it could be an effective anti-inflammatory agent. Since inflammation is central to the development of cancer cachexia, glycine supplementation represents a simple, safe and promising treatment. We tested the hypothesis that glycine supplementation reduces skeletal muscle inflammation and preserves muscle mass in tumor-bearing mice.To induce cachexia, CD2F1 mice received a subcutaneous injection of PBS (control, n = 12) or C26 tumor cells (n = 32) in accordance with the protocols developed by Murphy et al. [Murphy KT, Chee A, Trieu J, Naim T, Lynch GS. Importance of functional and metabolic impairments in the characterization of the C-26 murine model of cancer cachexia. Dis Models Mech 2012;5(4):533-545.]. Subcutaneous injections of glycine (n = 16) or PBS (n = 16) were administered daily for 21 days and at the conclusion of treatment, selected muscles, tumor and adipose tissue were collected and prepared for Real-Time RT-PCR or western blot analysis.Glycine attenuated the loss of fat and muscle mass, blunted increases in markers of inflammation (F4/80, P = 0.01 & IL-6 mRNA, P = 0.01) and atrophic signaling (MuRF, P = 0.047; atrogin-1, P = 0.04; LC3B, P = 0.06 and; BNIP3, P = 0.10) and tended to attenuate the loss of body mass (P = 0.07), muscle function (P = 0.06), and oxidative stress (GSSG/GSH, P = 0.06 and DHE, P = 0.07) seen in tumor-bearing mice. Preliminary studies that compared the effect of glycine administration with isonitrogenous doses of alanine or citrulline showed that the observed protective effect was specific to glycine.Glycine protects skeletal muscle from cancer-induced wasting and loss of function, reduces the oxidative and inflammatory burden, and reduces the expression of genes associated with muscle protein breakdown in cancer cachexia. Importantly, these effects were glycine specific." @default.
• W2065403921 created "2016-06-24" @default.
• W2065403921 creator A5007665906 @default.
• W2065403921 creator A5026614782 @default.
• W2065403921 creator A5039531920 @default.
• W2065403921 creator A5049787247 @default.
• W2065403921 creator A5082733546 @default.
• W2065403921 date "2014-06-01" @default.
• W2065403921 modified "2023-10-12" @default.
• W2065403921 title "Glycine administration attenuates skeletal muscle wasting in a mouse model of cancer cachexia" @default.
• W2065403921 cites W1967464711 @default.
• W2065403921 cites W1969630360 @default.
• W2065403921 cites W1996974556 @default.
• W2065403921 cites W2010579238 @default.
• W2065403921 cites W2016729073 @default.
• W2065403921 cites W2018572283 @default.
• W2065403921 cites W2033797333 @default.
• W2065403921 cites W2034391073 @default.
• W2065403921 cites W2051300385 @default.
• W2065403921 cites W2051804282 @default.
• W2065403921 cites W2054327613 @default.
• W2065403921 cites W2063093419 @default.
• W2065403921 cites W2063106718 @default.
• W2065403921 cites W2080692874 @default.
• W2065403921 cites W2106883683 @default.
• W2065403921 cites W2108073731 @default.
• W2065403921 cites W2108195113 @default.
• W2065403921 cites W2131441161 @default.
• W2065403921 cites W2132433704 @default.
• W2065403921 cites W2133739669 @default.
• W2065403921 cites W2135367382 @default.
• W2065403921 cites W2141217773 @default.
• W2065403921 cites W2145280166 @default.
• W2065403921 cites W2146917635 @default.
• W2065403921 cites W2152336472 @default.
• W2065403921 cites W2152807050 @default.
• W2065403921 cites W2168984459 @default.
• W2065403921 doi "https://doi.org/10.1016/j.clnu.2013.06.013" @default.
• W2065403921 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23835111" @default.
• W2065403921 hasPublicationYear "2014" @default.
• W2065403921 type Work @default.
• W2065403921 sameAs 2065403921 @default.
• W2065403921 citedByCount "72" @default.
• W2065403921 countsByYear W20654039212014 @default.
• W2065403921 countsByYear W20654039212015 @default.
• W2065403921 countsByYear W20654039212016 @default.
• W2065403921 countsByYear W20654039212017 @default.
• W2065403921 countsByYear W20654039212018 @default.
• W2065403921 countsByYear W20654039212019 @default.
• W2065403921 countsByYear W20654039212020 @default.
• W2065403921 countsByYear W20654039212021 @default.
• W2065403921 countsByYear W20654039212022 @default.
• W2065403921 countsByYear W20654039212023 @default.
• W2065403921 crossrefType "journal-article" @default.
• W2065403921 hasAuthorship W2065403921A5007665906 @default.
• W2065403921 hasAuthorship W2065403921A5026614782 @default.
• W2065403921 hasAuthorship W2065403921A5039531920 @default.
• W2065403921 hasAuthorship W2065403921A5049787247 @default.
• W2065403921 hasAuthorship W2065403921A5082733546 @default.
• W2065403921 hasConcept C104317684 @default.
• W2065403921 hasConcept C121608353 @default.
• W2065403921 hasConcept C126322002 @default.
• W2065403921 hasConcept C134018914 @default.
• W2065403921 hasConcept C171089720 @default.
• W2065403921 hasConcept C185592680 @default.
• W2065403921 hasConcept C2776151105 @default.
• W2065403921 hasConcept C2776415932 @default.
• W2065403921 hasConcept C2776914184 @default.
• W2065403921 hasConcept C2777704314 @default.
• W2065403921 hasConcept C2777756961 @default.
• W2065403921 hasConcept C2779764123 @default.
• W2065403921 hasConcept C2779959927 @default.
• W2065403921 hasConcept C515207424 @default.
• W2065403921 hasConcept C55493867 @default.
• W2065403921 hasConcept C71924100 @default.
• W2065403921 hasConceptScore W2065403921C104317684 @default.
• W2065403921 hasConceptScore W2065403921C121608353 @default.
• W2065403921 hasConceptScore W2065403921C126322002 @default.
• W2065403921 hasConceptScore W2065403921C134018914 @default.
• W2065403921 hasConceptScore W2065403921C171089720 @default.
• W2065403921 hasConceptScore W2065403921C185592680 @default.
• W2065403921 hasConceptScore W2065403921C2776151105 @default.
• W2065403921 hasConceptScore W2065403921C2776415932 @default.
• W2065403921 hasConceptScore W2065403921C2776914184 @default.
• W2065403921 hasConceptScore W2065403921C2777704314 @default.
• W2065403921 hasConceptScore W2065403921C2777756961 @default.
• W2065403921 hasConceptScore W2065403921C2779764123 @default.
• W2065403921 hasConceptScore W2065403921C2779959927 @default.
• W2065403921 hasConceptScore W2065403921C515207424 @default.
• W2065403921 hasConceptScore W2065403921C55493867 @default.
• W2065403921 hasConceptScore W2065403921C71924100 @default.
• W2065403921 hasFunder F4320320974 @default.
• W2065403921 hasFunder F4320324656 @default.
• W2065403921 hasFunder F4320334705 @default.
• W2065403921 hasIssue "3" @default.
• W2065403921 hasLocation W20654039211 @default.
• W2065403921 hasLocation W20654039212 @default.
• W2065403921 hasOpenAccess W2065403921 @default.

• next